SCHEMBL20723203

SCHEMBL20723203

CCc1c(C(=O)O)nc2c(-c3cccc(Cl)c3)c(C)nn2c1C(C)C

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 5/20 0.45
▸ THRB P10828 1/20 0.45
▸ PIN1 Q13526 1/20 0.41
▸ MDM2 Q00987 3/20 0.41
▸ NPSR1 Q6W5P4 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ PKM P14618 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20723047 0.90 MAPT (0.42) TP53THRBPIN1NPSR1MAPT
SCHEMBL20723218 0.87 CRHR1 (0.49) TP53THRBPIN1NPSR1MAPT
SCHEMBL20723241 0.82 CRHR1 (0.43) TP53NPSR1MAPTKDM4ETDP1
SCHEMBL20723262 0.78 MAPT (0.39) NPSR1MAPTKDM4ETDP1L3MBTL1
SCHEMBL20723101 0.77 TP53 (0.44) TP53THRBPIN1MDM2NPSR1
SCHEMBL20723261 0.77 TSHR (0.49) TP53NPSR1MAPTKDM4EL3MBTL1
SCHEMBL20723019 0.75 GLA (0.48) TP53THRBNPSR1MAPTKDM4E
SCHEMBL20723196 0.74 GABRA2 (0.49) TP53THRBNPSR1MAPTKDM4E
SCHEMBL20723240 0.74 GCGR (0.37) NPSR1MAPTKDM4ETDP1L3MBTL1
SCHEMBL20723099 0.73 TP53 (0.47) TP53THRBNPSR1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3664806-A1 APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2020-06-17 — — EP disclosed
WO-2019032720-A1 APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2019-02-14 — — WO disclosed
Send feedback